North America Omega 3 Market By Type, By Application, By Source, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

The North America Omega 3 Market is expected to witness market growth of 6.9% CAGR during the forecast period (2021-2027).

Omega-3 fatty acids are nutrients obtained from food (or supplements) that aid in the development and maintenance of a healthy body. It is important for the structure of every cell wall. Along with that, it also serves as an energy source and aid in the proper functioning of the heart, lungs, blood vessels, and immune system.

Many studies are being conducted to investigate the effect of omega-3 in baby food/infant nutrition due to the increasing popularity of omega-3 in other applications. It has been discovered that infants who consume DHA-enriched formula have better cognitive outcomes later in life. The majority of brain development in babies happens during pregnancy and the first two years of life. Infants require DHA and ARA throughout this time. These nutrients are crucial for brain development, which is why omega-3 infant nutrition supplements are becoming increasingly popular.

The United States Food and Drug Administration (FDA) has issued regulations that allow qualified health claims proving that these products can be used to reduce the risk of cardiovascular diseases, which is projected to raise its demand in this region. In addition, there is a rising investments by major corporations in the development of innovative technologies to increase the delivery and absorption of omega-3 acids in the body.

The US market dominated the North America Omega 3 Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $851.3 million by 2027. The Canada market is expected to witness a CAGR of 9.3% during (2021 - 2027). Additionally, The Mexico market is expected to showcase a CAGR of 8.3% during (2021 - 2027).

Based on Type, the market is segmented into Docosahexaenoic acid (DHA), Eicosapentaenoic acid (EPA), and Alpha-linolenic acid (ALA). Based on Application, the market is segmented into Supplements & Functional Foods, Pharmaceuticals, Infant Formula, Animal Feed & Pet Food and Others. Based on Source, the market is segmented into Marine Source and Plant Source. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Aker BioMarine AS, GC Rieber VivoMega AS (GC Rieber group), Epax Norway AS (Pelagia Holding AS), FMC Corporation, BASF SE, Koninklijke DSM N.V., Lonza Group AG, Orkla ASA (Orkla Health), Croda International PLC, and Omega Protein Corporation (Cooke, Inc.).

Scope of the Study

Market Segments Covered in the Report:

By Type

• Docosahexaenoic acid (DHA)
• Eicosapentaenoic acid (EPA), and
• Alpha-linolenic acid (ALA)

By Application

• Supplements & Functional Foods
• Pharmaceuticals
• Infant Formula
• Animal Feed & Pet Food and
• Others

By Source

• Marine Source and
• Plant Source

By Country

• US
• Canada
• Mexico
• Rest of North America

Key Market Players

List of Companies Profiled in the Report:

• Aker BioMarine AS
• GC Rieber VivoMega AS (GC Rieber group)
• Epax Norway AS (Pelagia Holding AS)
• FMC Corporation
• BASF SE
• Koninklijke DSM N.V.
• Lonza Group AG
• Orkla ASA (Orkla Health)
• Croda International PLC
• Omega Protein Corporation (Cooke, Inc.)

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free